Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT02852187

Single Center Study Comparing MOBIS II ST vs MOBIS PEEK

Prospective, Randomized, Data Registry Study of MOBIS II Structural Titanium (ST) Interbody Cage Compared to MOBIS Peek Cage for the Treatment of Spondylolisthesis and Degenerative Disc Disease

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Signus Medizintechnik GmbH · Industry
Sex
All
Age
18 Years – 89 Years
Healthy volunteers
Not accepted

Summary

Prospective randomized clinical study comparing SIGNUS MOBIS PEEK vs SIGNUS MOBIS II ST in patients with Degenerative Disc Disease at one or two contiguous levels from L2-S1

Detailed description

The protocol includes skeletally mature patients both male and female, 18 to 89 years old, with degenerative disc disease (DDD) at one or two contiguous levels from L2-S1. DDD is defined as discogenic back pain with degeneration of the disc confirmed by patient history and radiographic studies. Patients may also have up to a Grade I spondylolisthesis or retrolisthesis at the involved level(s). Patient should have completed at least six (6) months of non-operative treatment. Patients may have had a previous non-fusion surgery at the involved spinal level(s) and will be followed clinically up to two years.

Conditions

Interventions

TypeNameDescription
DEVICESIGNUS MOBIS PEEK CageLumbar Interbody Fusion
DEVICESIGNUS MOBIS II ST CageLumbar Interbody Fusion

Timeline

Start date
2016-07-01
Primary completion
2018-11-01
Completion
2018-11-01
First posted
2016-08-02
Last updated
2020-03-19

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02852187. Inclusion in this directory is not an endorsement.